Furthermore, our data demonstrated that the diagnostic accuracy of the TyG index was superior to those of ALT and AST/ALT ratio in identifying NAFLD risk in patients with T2DM. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.